CurveBeam and StraxCorp completed their previously-announced merger. Under the new name CurveBeam AI, the company expands CurveBeam’s point-of-care imaging solutions…
The combined organization creates the eighth-largest spine company, bolstered by a well-balanced portfolio spanning trauma, orthobiologics and bone growth therapies.
Zimmer Biomet entered into a three-year agreement with the Hospital for Special Surgery (HSS) to create the HSS/Zimmer Biomet Innovation…
Arthrex and Skytron will collaborate to expand advanced operating room technology and infrastructure solutions for hospitals and surgical centers.
Spine Innovations, a spin-off from Groupe FH Ortho’s spine activity, specializes in cervical and lumbar disc prostheses.
The collaboration will further strengthen and expand Altus’ bioceramic nanotube surface technologies throughout their portfolio.
The addition of CartiHeal will complement the company’s joint preservation technologies and specifically its HA business.
The transaction expands the enabling technologies platform for Enovis’’ reconstructive portfolio with augmented reality surgical guidance.
SNN is partnering with Rods&Cones to provide smart surgery glasses and digital remote assistance to customers, initially in the UK.
ExsoMed, whose products support an intermedullary approach to treat hand fractures, enhances Acumed’s portfolio of upper extremity solutions for simple to complex injuries.
The amended agreement reduces the closing payment to $50 million (plus $50 million deposited into escrow last year) from the original $315 million.
The move expands its portfolio of trauma and deformity systems for pediatric orthopedics, including the Fassier-Duval Telescopic IM System.
Onkos is expanding its musculoskeletal oncology portfolio with the JTS device to treat pediatric bone cancer.
In2Bones’ product portfolio includes implants, fracture systems, biologics and related hardware to treat upper and lower extremities.
The move allows Medartis to further accelerate its U.S. extremities business.
ORHub will enter the medical device market with biologics to regenerate cartilage and address degenerative disc disease and osteoarthritis.
The move will expand Isto’s portfolio of procedure-specific allografts for spine, orthopedic and sports medicine applications.
Don't have an account? Register
Forgot your password? Reset
Register for a free account
As a guest member you get access to more articles and webinars every month.
We noticed you used your personal email account. Please enter your company website URL.
Already have an account? Login
We’ll send a recovery link to your email.
I already have an account! Login